New version of GMP pharmaceutical industry certification system standard launched

According to the survey, the pharmaceutical industry grew by 23% in 2012, while the global pharmaceutical market grew by 42%, nearly 50%. China's share is less than 20%. The domestic pharmaceutical industry is still a sunrise industry. Pharmaceutical management system certification - GMP certification will be used more and more in China. The new version of GMP has stricter standards, and the medical industry is reshuffled. Some companies may face transformation. So, is the launch of the new version of GMP pharmaceutical industry certification system standards the spring or winter of the pharmaceutical industry?

1. New version of GMP, spring for the pharmaceutical industry

With the improvement of national income level, the country's attention to people's livelihood issues, the continuous increase in medical investment, the increase in demand for medical services brought about by deep urbanization, and the growth of government-led medical service supply, the pharmaceutical industry has attracted much attention, and the benefiting industries have been discovered by the market one after another. The pharmaceutical industry may usher in spring.

1. Many favorable factors

As a small-capacity industry, medicine is not as eye-catching as infrastructure and finance. In addition, it is difficult for ordinary investors to systematically sort out the different sub-sectors. However, stimulated by a number of favorable factors, the pharmaceutical industry has shown great growth potential.

2. Huge potential market

In 2012, the domestic pharmaceutical market exceeded RMB 100 billion, with an average annual growth rate of about 23%. It is expected that the market size will reach RMB 340 billion by 2015. It is worth noting that compared with 42% of the global pharmaceutical market, the share of pharmaceuticals in my country is only 14%, so the potential market is quite broad.

2. The new GMP standards are more stringent, and the pharmaceutical industry is reshuffled. Is winter coming?

The new GMP has high requirements for sterile preparation companies, requiring all of them to pass it by the end of 2013; the last is substitution. Nowadays, many high-end medicines are imported from abroad, and with the gradual upgrading of technology, domestic high-end medicines have gradually possessed substitution capabilities, and the pharmaceutical industry has been reshuffled. Recommended article: >>> How to pass the factory inspection smoothly

The launch of the new GMP pharmaceutical industry certification system standard, is it the spring or winter of the pharmaceutical industry? It is still unknown. If you want to know more about this, you can contact our online customer service or call us for detailed information. We will not only provide you with the most professional factory inspection information but also the most suitable solutions for the factory. SuperNet senior experts are waiting for your consultation!